Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
Biochimica Et Biophysica Acta|December 8, 1989
Purification and properties of a new ribosome-inactivating protein with RNA N-glycosidase activity suitable for immunotoxin preparation from the seeds of Momordica cochinchinensisA Bolognesi, L Barbieri, D Carnicelli, et al.
FEBS Letters|November 4, 1996
A systemic antiviral resistance-inducing protein isolated from Clerodendrum inerme Gaertn. is a polynucleotide:adenosine glycosidase (ribosome-inactivating protein)F Olivieri, V Prasad, P Valbonesi, et al.
Journal of Mass Spectrometry : JMS|February 17, 2001
Reliable sequence determination of ribosome- inactivating proteins by combining electrospray mass spectrometry and Edman degradationA Di Maro, P Ferranti, M Mastronicola, et al.
Journal of Hematotherapy|October 1, 1995
Targeting of type 1 ribosome-inactivating proteins to CD30+ or CD25+ hematologic neoplasias by bispecific antibodiesS Sforzini, A Bolognesi, R Meazza, et al.
International Journal of Cancer|April 1, 1991
Intra-thecal treatment of leptomeningeal lymphoma with immunotoxinC E Urch, A J George, G T Stevenson, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1993
In vitro and in vivo properties of an anti-CD5-momordin immunotoxin on normal and neoplastic T lymphocytesG Porro, A Bolognesi, P Caretto, et al.
Leukemia|April 23, 2004
The conjugate Rituximab/saporin-S6 completely inhibits clonogenic growth of CD20-expressing cells and produces a synergistic toxic effect with FludarabineL Polito, A Bolognesi, P L Tazzari, et al.
British Journal of Cancer|September 1, 1989
An immunotoxin containing momordin suitable for bone marrow purging in multiple myeloma patientsA Dinota, L Barbieri, M Gobbi, et al.
British Journal of Cancer|June 1, 1993
Targeting of saporin to CD25-positive normal and neoplastic lymphocytes by an anti-saporin/anti-CD25 bispecific monoclonal antibody: in vitro evaluationP L Tazzari, S Zhang, Q Chen, et al.
British Journal of Haematology|May 12, 1998
Evaluation of immunotoxins containing single-chain ribosome-inactivating proteins and an anti-CD22 monoclonal antibody (OM124): in vitro and in vivo studiesA Bolognesi, P L Tazzari, F Olivieri, et al.
Pageof 9